EA201600331A1 - PHARMACEUTICAL COMPOSITION IN THE FORM OF SOLUTION FOR INTRAVENOUS AND INTRAINAL INTRODUCTION AND METHOD FOR ITS PREPARATION - Google Patents

PHARMACEUTICAL COMPOSITION IN THE FORM OF SOLUTION FOR INTRAVENOUS AND INTRAINAL INTRODUCTION AND METHOD FOR ITS PREPARATION

Info

Publication number
EA201600331A1
EA201600331A1 EA201600331A EA201600331A EA201600331A1 EA 201600331 A1 EA201600331 A1 EA 201600331A1 EA 201600331 A EA201600331 A EA 201600331A EA 201600331 A EA201600331 A EA 201600331A EA 201600331 A1 EA201600331 A1 EA 201600331A1
Authority
EA
Eurasian Patent Office
Prior art keywords
intravenous
solution
pharmaceutical composition
intrainal
introduction
Prior art date
Application number
EA201600331A
Other languages
Russian (ru)
Other versions
EA034722B1 (en
Original Assignee
Закрытое Акционерное Общество "Фармфирма "Сотекс"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрытое Акционерное Общество "Фармфирма "Сотекс" filed Critical Закрытое Акционерное Общество "Фармфирма "Сотекс"
Publication of EA201600331A1 publication Critical patent/EA201600331A1/en
Publication of EA034722B1 publication Critical patent/EA034722B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к области медицины и химико-фармацевтической промышленности, а именно к лекарственному средству в форме раствора для инъекций для лечения заболеваний головного мозга и способу получения этого лекарственного средства. Заявлен состав фармацевтической композиции в форме раствора для внутривенного и внутримышечного введения, содержащий в качестве активного ингредиента 6-метил-2-этилпиридин-3-ол соль (2S)-2-ацетаминопентандиовой кислоты, а также способ получения указанной композиции. Заявленная группа изобретений позволяет впервые получить готовую лекарственную форму на основе 6-метил-2-этилпиридин-3-ол соль (2S)-2-ацетаминопентандиовой кислоты.The invention relates to the field of medicine and the pharmaceutical industry, namely to the drug in the form of an injection for the treatment of diseases of the brain and the method of obtaining this drug. The claimed composition of the pharmaceutical composition in the form of a solution for intravenous and intramuscular administration, containing as active ingredient 6-methyl-2-ethylpyridin-3-ol salt (2S) -2-acetaminopentanedioic acid, as well as a method of obtaining this composition. The claimed group of inventions allows for the first time to obtain a finished dosage form based on 6-methyl-2-ethylpyridin-3-ol salt of (2S) -2-acetaminopentanedioic acid.

EA201600331A 2015-03-12 2016-02-25 Pharmaceutical composition in the form of intravenous and intramuscular solution and method of production thereof EA034722B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015108664A RU2637168C2 (en) 2015-03-12 2015-03-12 Pharmaceutical composition in form of solute for intravenous and intramuscular injection and its production process

Publications (2)

Publication Number Publication Date
EA201600331A1 true EA201600331A1 (en) 2016-10-31
EA034722B1 EA034722B1 (en) 2020-03-12

Family

ID=53433611

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201600331A EA034722B1 (en) 2015-03-12 2016-02-25 Pharmaceutical composition in the form of intravenous and intramuscular solution and method of production thereof

Country Status (2)

Country Link
EA (1) EA034722B1 (en)
RU (1) RU2637168C2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2284993C2 (en) * 2002-06-14 2006-10-10 Леонид Дмитриевич Смирнов 2-ethyl-6-methyl-3-oxypyrodine salts with organic carboxylic acids possessing anxiolytic, antidepressive, antihypoxic, anti-amnestic and anti-oxidative activity and method for their preparing
RU2357955C2 (en) * 2006-04-21 2009-06-10 Смирнова Лариса Каземировна Antioxidant, antihyperglycemic, hypolipidemic and antishock n-acetylcysteinate 2-ethyl-6-methyl-3-hydroxypyridine
RU2380089C2 (en) * 2008-04-04 2010-01-27 Закрытое Акционерное Общество "Фармфирма "Сотекс" Pharmaceutical composition for injections
RU2504376C1 (en) * 2012-05-04 2014-01-20 Галина Викторовна Сукоян High-stable pharmaceutical formulation of lyophilisate of 3-oxypyridine and methylpyridine derivatives and pharmaceutically acceptable salts thereof
RU2493841C1 (en) * 2012-10-09 2013-09-27 Станислав Анатольевич Кедик Synergetic preparation for treating cardiovascular diseases, diabetes mellitus and hepatobiliary diseases

Also Published As

Publication number Publication date
RU2015108664A (en) 2015-06-20
EA034722B1 (en) 2020-03-12
RU2637168C2 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
CY1118826T1 (en) PROCEDURE FOR CONSTRUCTION OF A GLATIRAMER ACETATE CONTAINER
EA202090573A1 (en) COMPOSITIONS OF NIRAPARIBA
NI201100194A (en) DERIVATIVES OF HAVE [2, 3 - B] PYRIDINE AS INHIBITORS OF VIRAL REPLICATION
NZ631100A (en) Soft chewable pharmaceutical products
EA201791727A1 (en) 7-BENZYL-4- (2-METHYLBENZIL) -2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A] PYRIDO [3,4-E] PYRIMIDIN-5 (1H) -OH, ITS ANALOGUES AND SALTS AND METHODS OF THEIR APPLICATION IN THERAPY
EA201590697A1 (en) DERIVATIVES OF KETAMINE
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
EA201590797A1 (en) PREPARATIONS WITH THE MODIFIED PROBE RELEASE
EA201501054A1 (en) TREATMENT OF MYOPATHIES AND NEURODEGENERATIVE DISEASES ASSOCIATED WITH THE PROTECTION OF PROTEINS BY PARENTAL INTRODUCTION OF TRAGOSE
CY1122899T1 (en) AQUEOUS FORMULATION INCLUDING PARACETAMOL AND IBUPROPHEN
EA201491427A1 (en) SUBSTITUTED PHENYLIMIDAZOPIRAZOLES AND THEIR APPLICATION
EA201690183A1 (en) SUBSTITUTED PYRAZOLOPIRIDINAMINES
FI3383385T4 (en) Melflufen dosage regimens for cancer
EA201691693A3 (en) COMBINED MEDICINE PREPARATION IN THE FORM OF SPELLING TABLETS AND METHOD OF ITS PREPARATION
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
EA201600331A1 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF SOLUTION FOR INTRAVENOUS AND INTRAINAL INTRODUCTION AND METHOD FOR ITS PREPARATION
BR112018008769A2 (en) pharmaceutical formulations, reconstituted and lyophilized aqueous liquid formulations, syringe, method of manufacturing a pharmaceutical formulation, method for treating a disease and use of a reconstructed formulation
EA201391512A1 (en) SOLID PHARMACEUTICAL COMPOSITION
EA201790140A1 (en) PHARMACEUTICAL MEDICINE FORMS
EA201600332A3 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS COVERED WITH THE INTESTINAL SOLUTION SHELL, AND THE METHOD OF ITS OBTAINING
EA201992816A1 (en) PHARMACEUTICAL COMPOSITION AND MEDICINAL FORM THAT INCLUDES (E) -4- (2- (AMINOMETHYL) -3-FLOROLLYLOXY) -N-THR-BUTYLBENZAMIDE, METHOD FOR THEIR PREPARATION AND APPLICATION, APPLICATION
EA201491477A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLUPIRTIN
UA117389C2 (en) MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION
EA201600336A3 (en) MEDICINE FOR PREVENTION AND TREATMENT OF BRAIN DISEASES AND METHOD FOR TREATING BRAIN DISEASES
WO2016115442A3 (en) Therapeutic protein formulations